<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28646182</article-id><article-id pub-id-type="pmc">5482849</article-id><article-id pub-id-type="publisher-id">4035</article-id><article-id pub-id-type="doi">10.1038/s41598-017-04035-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>High-intensity Interval Training Improves Mitochondrial Function and Suppresses Thrombin Generation in Platelets undergoing Hypoxic Stress</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Li-Hua</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Chang</surname><given-names>Shao-Chiang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Tieh-Cheng</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Ching-Hui</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Jong-Shyan</given-names></name><address><email>s5492@mail.cgu.edu.tw</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.145695.a</institution-id><institution>Healthy Aging Research Center, Graduate Institute of Rehabilitation Science, </institution><institution>Medical Collage, Chang Gung University, </institution></institution-wrap>Tao-Yuan, Taiwan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0639 2551</institution-id><institution-id institution-id-type="GRID">grid.454209.e</institution-id><institution>Heart Failure Center, Department of Physical Medicine and Rehabilitation, </institution><institution>Chang Gung Memorial Hospital, </institution></institution-wrap>Keelung, Taiwan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.418428.3</institution-id><institution>Research Center for Chinese Herbal Medicine, College of Human Ecology, </institution><institution>Chang Gung University of Science and Technology, </institution></institution-wrap>Tao-Yuan, Taiwan </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>7</volume><elocation-id>4191</elocation-id><history><date date-type="received"><day>6</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>8</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">This study elucidates how high-intensity interval training (HIT) and moderate-intensity continuous training (MCT) affect mitochondrial functionality and thrombin generation (TG) in platelets following hypoxic exercise (HE, 100&#x02009;W under 12% O<sub>2</sub> for 30&#x02009;min). Forty-five healthy sedentary males were randomized to engage either HIT (3-minute intervals at 40% and 80%VO<sub>2max</sub>, n&#x02009;=&#x02009;15) or MCT (sustained 60%VO<sub>2max</sub>, n&#x02009;=&#x02009;15) for 30&#x02009;minutes/day, 5 days/week for 6 weeks, or to a control group (CTL, n&#x02009;=&#x02009;15) that did not received exercise intervention. Before the intervention, HE (i) reduced the ATP-linked O<sub>2</sub> consumption rate (OCR), the reserve capacity of OCR, and the activities of citrate synthase (CS) and succinate dehydrogenase (SDH), (ii) lowered mitochondrial membrane potential (MP) and elevated matrix oxidant burden (MOB) in platelets, and (iii) enhanced dynamic TG in platelet-rich plasma (PRP), which responses were attenuated by pretreating PRP with oligomycin or rotenone/antimycin A. However, 6-week HIT (i) increased mitochondrial OCR capacity with enhancing the CS and SDH activities and (ii) heightened mitochondrial MP with depressing MOB in platelets following HE, compared to those of MCT and CTL. Moreover, the HIT suppressed the HE-promoted dynamic TG in PRP. Hence, we conclude that the HIT simultaneously improves mitochondrial bioenergetics and suppresses dynamic TG in platelets undergoing hypoxia.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Regular exercise may reduce the risk of major vascular thrombotic events and protect people against cardiovascular diseases<sup><xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref></sup>. Moreover, high-intensity exercise elicits a greater central hemodynamic adaptation than low and moderate levels of exercise<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. However physical exercise imposes, paradoxically, both enhancing and suppressing effects on platelet reactivity and coagulation, depending on the type and intensity of exercise<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Systemic hypoxia has detrimental effects on the haemostatic system, such as accelerating prothrombinase complex assembly and facilitating thrombin generation (TG)<sup><xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref></sup>. Pathological investigations have also demonstrated that a hypercoagulable state contributes to increased risks of vascular thrombotic events in patients with episodic hypoxia, such as obstructive sleep apnea<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> and chronic obstructive pulmonary disease<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. To the best of our knowledge, what kind of exercise strategy improves aerobic capacity and simultaneously increases the resistance to thrombotic risk provoked by hypoxia has not yet been established.</p><p id="Par3">Increased thrombin activity is an essential pathogenic process of cardiovascular diseases<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Functional mitochondria in platelet has demonstrated the direct involvements of the cellular ATP production, redox balance, and thrombogenesis<sup><xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref></sup>. Platelet activation results in its mitochondrial membrane potential collapse and reactive oxygen species (ROS) production, consequently facilitating the exposure of phosphatidylserine (PS)<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. The negatively charged PS on platelets can bind coagulant factors VIII (FVIII), Va, and Xa, providing a strongly catalytic surface for the assembly of prothrombinase and tenase, thus triggering TG in blood<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Our early study further demonstrated that severe hypoxic exposure (12% O<sub>2</sub>) promoted FVIII-dependent TG by elevating oxidative stress; this hypoxic effect was ameliorated by pretreatment with antioxidant vitamin E<sup>5</sup>. However, a previous study has indicated that exercise training decreased the coagulant factor expression and PS exposure of platelets and the shedding of procoagulant microparticles from platelets, thereby depressing dynamic TG in platelets<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p><p id="Par4">Warm-up exercise (40%VO<sub>2max</sub>) has been shown to reduce high-intensity exercise (80%VO<sub>2max</sub>)-induced risks of inflammatory thrombosis associated with leukocytes and platelets, which is a form of preconditioning<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Recently, our investigation revealed that high-intensity interval exercise training (HIT) that consists of alternating mild-(40%VO<sub>2max</sub>) and high-(80%VO<sub>2max</sub>) intensity exercise significantly suppressed neutrophil-promoted blood coagulation by down-regulating expression of procoagulant factors under hypoxic condition<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Accordingly, we further hypothesize that HIT effectively reduces platelet-induced TG undergoing hypoxic stress, which is associated with alleviating platelet mitochondrial dysfunction cause by hypoxia.</p><p id="Par5">To answer the abovementioned questions, this study evaluated how two isovolumic exercise regimens [<italic>i</italic>.<italic>e</italic>., HIT (3-minute intervals at 40% and 80%VO<sub>2max</sub>) and moderate-intensity continuous exercise training (MCT, sustained 60%VO<sub>2max</sub>)] for 6 weeks affected (i) mitochondrial oxidative phosphorylation (OXPHOS) and oxidative stress, (ii) mitochondrial biogenesis, and (iii) dynamic TG in platelets following hypoxic exercise (HE, 100&#x02009;W under 12% O<sub>2</sub> for 30&#x02009;min). The aim of the present study is to establish an effective exercise strategy for improving individual aerobic capacity and simultaneously ameliorating the risk of platelet mitochondrial dysfunction and subsequent TG evoked by hypoxic stress.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Aerobic fitness</title><p id="Par6">Anthropometric variables did not significantly differ among the three groups at the beginning of the study (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Both HIT and MCT for 6 weeks lowered HR and systolic blood pressure at rest, as well as, increased work-rate, minute ventilation (V<sub>E</sub>), O<sub>2</sub> consumption (VO<sub>2</sub>), and CO<sub>2</sub> production (VCO<sub>2</sub>) at the ventilation threshold and peak performance (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). Moreover, the HIT group exhibited a greater improvement in pulmonary ventilation and aerobic capacity than did the MCT group (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). However, control subjects that did not receive exercise intervention (CTL) for 6 weeks showed no changes in these cardiopulmonary responses to a graded exercise test (GXT) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>The effects of interval and continuous exercise regimens on exercise performance.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="2">HIT</th><th colspan="2">MCT</th><th colspan="2">CTL</th></tr><tr><th>Pre</th><th>Post</th><th>Pre</th><th>Post</th><th>Pre</th><th>Post</th></tr></thead><tbody><tr><td colspan="7">
<bold><italic>Anthropometric parameters</italic></bold>
</td></tr><tr><td>Age (year)</td><td>22.2&#x02009;&#x000b1;&#x02009;0.4</td><td>&#x02014;</td><td>22.1&#x02009;&#x000b1;&#x02009;0.5</td><td>&#x02014;</td><td>21.9&#x02009;&#x000b1;&#x02009;0.7</td><td>&#x02014;</td></tr><tr><td>Height (cm)</td><td>171.0&#x02009;&#x000b1;&#x02009;1.0</td><td>&#x02014;</td><td>172.1&#x02009;&#x000b1;&#x02009;1.2</td><td>&#x02014;</td><td>172.2&#x02009;&#x000b1;&#x02009;1.3</td><td>&#x02014;</td></tr><tr><td>Weight (kg)</td><td>69.7&#x02009;&#x000b1;&#x02009;1.1</td><td>70.3&#x02009;&#x000b1;&#x02009;2.1</td><td>67.3&#x02009;&#x000b1;&#x02009;1.9</td><td>67.0&#x02009;&#x000b1;&#x02009;1.8</td><td>67.8&#x02009;&#x000b1;&#x02009;3.1</td><td>67.8&#x02009;&#x000b1;&#x02009;3.1</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>23.8&#x02009;&#x000b1;&#x02009;0.5</td><td>23.4&#x02009;&#x000b1;&#x02009;0.6</td><td>22.0&#x02009;&#x000b1;&#x02009;0.5</td><td>21.9&#x02009;&#x000b1;&#x02009;0.5</td><td>22.3&#x02009;&#x000b1;&#x02009;0.8</td><td>22.3&#x02009;&#x000b1;&#x02009;0.8</td></tr><tr><td>HR (beats/min)</td><td>72&#x02009;&#x000b1;&#x02009;1</td><td>68&#x02009;&#x000b1;&#x02009;2<sup>+</sup>
</td><td>71&#x02009;&#x000b1;&#x02009;2</td><td>67&#x02009;&#x000b1;&#x02009;2<sup>+</sup>
</td><td>73&#x02009;&#x000b1;&#x02009;2</td><td>72&#x02009;&#x000b1;&#x02009;3</td></tr><tr><td>SBP (mmHg)</td><td>120&#x02009;&#x000b1;&#x02009;2</td><td>115&#x02009;&#x000b1;&#x02009;2<sup>+</sup>
</td><td>121&#x02009;&#x000b1;&#x02009;3</td><td>116&#x02009;&#x000b1;&#x02009;3<sup>+</sup>
</td><td>123&#x02009;&#x000b1;&#x02009;2</td><td>122&#x02009;&#x000b1;&#x02009;3</td></tr><tr><td>DBP (mmHg)</td><td>74&#x02009;&#x000b1;&#x02009;2</td><td>72&#x02009;&#x000b1;&#x02009;2</td><td>74&#x02009;&#x000b1;&#x02009;3</td><td>72&#x02009;&#x000b1;&#x02009;2</td><td>75&#x02009;&#x000b1;&#x02009;3</td><td>74&#x02009;&#x000b1;&#x02009;3</td></tr><tr><td colspan="7">
<bold><italic>Ventilation threshold</italic></bold>
</td></tr><tr><td>Work-rate (watt)</td><td>100&#x02009;&#x000b1;&#x02009;5</td><td>156.5&#x02009;&#x000b1;&#x02009;7.5*<sup>+</sup>
</td><td>99.4&#x02009;&#x000b1;&#x02009;5.7</td><td>131.8&#x02009;&#x000b1;&#x02009;6.0*</td><td>104.0&#x02009;&#x000b1;&#x02009;6.2</td><td>108.1&#x02009;&#x000b1;&#x02009;6.2</td></tr><tr><td>HR (beats/min)</td><td>133&#x02009;&#x000b1;&#x02009;2</td><td>154&#x02009;&#x000b1;&#x02009;2.8*<sup>+</sup>
</td><td>134&#x02009;&#x000b1;&#x02009;3</td><td>146&#x02009;&#x000b1;&#x02009;4.0*</td><td>132&#x02009;&#x000b1;&#x02009;4</td><td>134&#x02009;&#x000b1;&#x02009;5</td></tr><tr><td>
<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\dot{{\rm{V}}}$$\end{document}</tex-math><mml:math id="M2"><mml:mover accent="true"><mml:mi mathvariant="normal">V</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41598_2017_4035_Article_IEq1.gif"/></alternatives></inline-formula>
<sub>E</sub> (l/min)</td><td>36.2&#x02009;&#x000b1;&#x02009;1.8</td><td>53.5&#x02009;&#x000b1;&#x02009;3.0*<sup>+</sup>
</td><td>36.5&#x02009;&#x000b1;&#x02009;2.1</td><td>47.0&#x02009;&#x000b1;&#x02009;2.6*</td><td>35.2&#x02009;&#x000b1;&#x02009;4.2</td><td>36.5&#x02009;&#x000b1;&#x02009;2.6</td></tr><tr><td>
<inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\dot{{\rm{V}}}$$\end{document}</tex-math><mml:math id="M4"><mml:mover accent="true"><mml:mi mathvariant="normal">V</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41598_2017_4035_Article_IEq2.gif"/></alternatives></inline-formula>O<sub>2</sub> (ml/min/kg)</td><td>16.4&#x02009;&#x000b1;&#x02009;0.7</td><td>23.8&#x02009;&#x000b1;&#x02009;1.0*<sup>+</sup>
</td><td>17.5&#x02009;&#x000b1;&#x02009;0.7</td><td>21.2&#x02009;&#x000b1;&#x02009;0.9*</td><td>16.9&#x02009;&#x000b1;&#x02009;0.9</td><td>17.0&#x02009;&#x000b1;&#x02009;0.8</td></tr><tr><td>
<inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\dot{{\rm{V}}}$$\end{document}</tex-math><mml:math id="M6"><mml:mover accent="true"><mml:mi mathvariant="normal">V</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41598_2017_4035_Article_IEq3.gif"/></alternatives></inline-formula>CO<sub>2</sub> (ml/min/kg)</td><td>16.5&#x02009;&#x000b1;&#x02009;0.7</td><td>23.8&#x02009;&#x000b1;&#x02009;1.0*<sup>+</sup>
</td><td>17.5&#x02009;&#x000b1;&#x02009;0.7</td><td>21.4&#x02009;&#x000b1;&#x02009;1.1*</td><td>17.0&#x02009;&#x000b1;&#x02009;0.9</td><td>17.2&#x02009;&#x000b1;&#x02009;0.9</td></tr><tr><td colspan="7">
<bold><italic>Peak performance</italic></bold>
</td></tr><tr><td>Work-rate (watt)</td><td>184.7&#x02009;&#x000b1;&#x02009;6.3</td><td>237.6&#x02009;&#x000b1;&#x02009;7.0*<sup>+</sup>
</td><td>182.4&#x02009;&#x000b1;&#x02009;5.4</td><td>213.5&#x02009;&#x000b1;&#x02009;5.5*</td><td>180&#x02009;&#x000b1;&#x02009;7</td><td>182&#x02009;&#x000b1;&#x02009;9</td></tr><tr><td>HR (beats/min)</td><td>194&#x02009;&#x000b1;&#x02009;2</td><td>195&#x02009;&#x000b1;&#x02009;2</td><td>193&#x02009;&#x000b1;&#x02009;2</td><td>194&#x02009;&#x000b1;&#x02009;2</td><td>195&#x02009;&#x000b1;&#x02009;3</td><td>194&#x02009;&#x000b1;&#x02009;2</td></tr><tr><td>
<inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\dot{{\rm{V}}}$$\end{document}</tex-math><mml:math id="M8"><mml:mover accent="true"><mml:mi mathvariant="normal">V</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41598_2017_4035_Article_IEq4.gif"/></alternatives></inline-formula>
<sub>E</sub> (l/min)</td><td>103.3&#x02009;&#x000b1;&#x02009;3.0</td><td>133.6&#x02009;&#x000b1;&#x02009;4.2*<sup>+</sup>
</td><td>98.7&#x02009;&#x000b1;&#x02009;3.5</td><td>114.1&#x02009;&#x000b1;&#x02009;3.2*</td><td>105.1&#x02009;&#x000b1;&#x02009;4.1</td><td>104.2&#x02009;&#x000b1;&#x02009;5.1</td></tr><tr><td>
<inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\dot{{\rm{V}}}$$\end{document}</tex-math><mml:math id="M10"><mml:mover accent="true"><mml:mi mathvariant="normal">V</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41598_2017_4035_Article_IEq5.gif"/></alternatives></inline-formula>O<sub>2</sub> (ml/min/kg)</td><td>31.7&#x02009;&#x000b1;&#x02009;0.5</td><td>39.7&#x02009;&#x000b1;&#x02009;0.6*<sup>+</sup>
</td><td>32.2&#x02009;&#x000b1;&#x02009;0.6</td><td>36.2&#x02009;&#x000b1;&#x02009;0.6*</td><td>31.4&#x02009;&#x000b1;&#x02009;0.6</td><td>31.4&#x02009;&#x000b1;&#x02009;0.6</td></tr><tr><td>
<inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\dot{{\rm{V}}}$$\end{document}</tex-math><mml:math id="M12"><mml:mover accent="true"><mml:mi mathvariant="normal">V</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41598_2017_4035_Article_IEq6.gif"/></alternatives></inline-formula>CO<sub>2</sub> (ml/min/kg)</td><td>38.0&#x02009;&#x000b1;&#x02009;0.6</td><td>47.4&#x02009;&#x000b1;&#x02009;0.7<sup>*,+</sup>
</td><td>38.6&#x02009;&#x000b1;&#x02009;0.8</td><td>43.4&#x02009;&#x000b1;&#x02009;0.8*</td><td>37.7&#x02009;&#x000b1;&#x02009;0.7</td><td>37.5&#x02009;&#x000b1;&#x02009;0.6</td></tr></tbody></table><table-wrap-foot><p>Values were mean&#x02009;&#x000b1;&#x02009;SEM. HIT, high-intensity interval training group; MCT, moderate-intensity continuous training group; CTL, control group; Pre, pre-intervention; Post, post-intervention; BMI, body mass index; <inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\dot{{\rm{V}}}$$\end{document}</tex-math><mml:math id="M14"><mml:mover accent="true"><mml:mi mathvariant="normal">V</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41598_2017_4035_Article_IEq7.gif"/></alternatives></inline-formula>
<sub>E</sub>, minute ventilation; <inline-formula id="IEq8"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\dot{{\rm{V}}}$$\end{document}</tex-math><mml:math id="M16"><mml:mover accent="true"><mml:mi mathvariant="normal">V</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41598_2017_4035_Article_IEq8.gif"/></alternatives></inline-formula>O<sub>2</sub>, oxygen consumption; <inline-formula id="IEq9"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\dot{{\rm{V}}}$$\end{document}</tex-math><mml:math id="M18"><mml:mover accent="true"><mml:mi mathvariant="normal">V</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41598_2017_4035_Article_IEq9.gif"/></alternatives></inline-formula>CO<sub>2</sub>, carbon dioxide production. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, Pre vs. Post; <sup>+</sup>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, HIT vs. MCT.</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec4"><title>Mitochondrial membrane potential (MP), matrix oxidant burden (MOB), and biogenesis in platelets</title><p id="Par7">Acute bout of 12% O<sub>2</sub> exercise significantly increased platelet counts in blood (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). However, blood platelet counts before or after the HE test remained unchanged following the 6-week intervention with HIT, MCT or CTL (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> shows the analysis of platelet mitochondrial count (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1e&#x02013;h</xref>), MP (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1i&#x02013;l</xref>), and MOB (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1m&#x02013;p</xref>) using a FACScan flow cytometer. Although no changes were observed in the mitochondrial count (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a&#x02013;c</xref>), the HE decreased the mitochondrial MP (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d&#x02013;f</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and elevated the MOB (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2g&#x02013;i</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) in platelets. After 6 weeks of the intervention, HIT, rather than MCT, inhibited the HE-induced decrease of mitochondrial MP (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and increase of MOB (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2g</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) in platelets. However, no significant changes in the mitochondrial count, MP, and MOB of platelets were observed after CTL for 6 weeks (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c,f,i</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>The effects of interval and continuous exercise regimens on platelet count and mitochondrial biogenesis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2"/><th colspan="2">HIT</th><th colspan="2">MCT</th><th colspan="2">CTL</th></tr><tr><th>Pre</th><th>Post</th><th>Pre</th><th>Post</th><th>Pre</th><th>Post</th></tr></thead><tbody><tr><td colspan="8">
<bold><italic>Platelet count (x10</italic></bold>
<sup><bold><italic>3</italic></bold></sup>
<bold><italic>cells/&#x003bc;l)</italic></bold>
</td></tr><tr><td/><td>R</td><td>224&#x02009;&#x000b1;&#x02009;11</td><td>216&#x02009;&#x000b1;&#x02009;12</td><td>232&#x02009;&#x000b1;&#x02009;10</td><td>226&#x02009;&#x000b1;&#x02009;18</td><td>234&#x02009;&#x000b1;&#x02009;12</td><td>237&#x02009;&#x000b1;&#x02009;9</td></tr><tr><td/><td>HE</td><td>264&#x02009;&#x000b1;&#x02009;21*</td><td>252&#x02009;&#x000b1;&#x02009;23*</td><td>272&#x02009;&#x000b1;&#x02009;16*</td><td>266&#x02009;&#x000b1;&#x02009;12*</td><td>284&#x02009;&#x000b1;&#x02009;20*</td><td>287&#x02009;&#x000b1;&#x02009;17*</td></tr><tr><td colspan="8">
<bold><italic>Platelet mitochondrial biogenesis (mean fluorescence intensity)</italic></bold>
</td></tr><tr><td>Complex II</td><td>R</td><td>21.7&#x02009;&#x000b1;&#x02009;2.8</td><td>22.1&#x02009;&#x000b1;&#x02009;2.4</td><td>22.6&#x02009;&#x000b1;&#x02009;1.9</td><td>22.5&#x02009;&#x000b1;&#x02009;2.6</td><td>23.5&#x02009;&#x000b1;&#x02009;1.9</td><td>23.4&#x02009;&#x000b1;&#x02009;2.5</td></tr><tr><td/><td>HE</td><td>21.6&#x02009;&#x000b1;&#x02009;2.3</td><td>23.1&#x02009;&#x000b1;&#x02009;2.8</td><td>23.0&#x02009;&#x000b1;&#x02009;1.6</td><td>23.9&#x02009;&#x000b1;&#x02009;2.5</td><td>23.7&#x02009;&#x000b1;&#x02009;2.1</td><td>24.3&#x02009;&#x000b1;&#x02009;1.7</td></tr><tr><td>Complex IV</td><td>R</td><td>16.9&#x02009;&#x000b1;&#x02009;2.8</td><td>17.0&#x02009;&#x000b1;&#x02009;2.5</td><td>16.3&#x02009;&#x000b1;&#x02009;1.7</td><td>16.9&#x02009;&#x000b1;&#x02009;2.1</td><td>17.4&#x02009;&#x000b1;&#x02009;1.3</td><td>16.9&#x02009;&#x000b1;&#x02009;1.5</td></tr><tr><td/><td>HE</td><td>16.0&#x02009;&#x000b1;&#x02009;2.7</td><td>17.1&#x02009;&#x000b1;&#x02009;1.9</td><td>16.7&#x02009;&#x000b1;&#x02009;1.1</td><td>16.8&#x02009;&#x000b1;&#x02009;1.4</td><td>16.9&#x02009;&#x000b1;&#x02009;1.7</td><td>17.0&#x02009;&#x000b1;&#x02009;0.8</td></tr><tr><td colspan="8">Ratio of Complex IV to Complex II</td></tr><tr><td/><td>R</td><td>0.78&#x02009;&#x000b1;&#x02009;0.04</td><td>0.77&#x02009;&#x000b1;&#x02009;0.03</td><td>0.72&#x02009;&#x000b1;&#x02009;0.05</td><td>0.71&#x02009;&#x000b1;&#x02009;0.04</td><td>0.74&#x02009;&#x000b1;&#x02009;0.04</td><td>0.72&#x02009;&#x000b1;&#x02009;0.03</td></tr><tr><td/><td>HE</td><td>0.74&#x02009;&#x000b1;&#x02009;0.06</td><td>0.73&#x02009;&#x000b1;&#x02009;0.04</td><td>0.73&#x02009;&#x000b1;&#x02009;0.04</td><td>0.72&#x02009;&#x000b1;&#x02009;0.05</td><td>0.71&#x02009;&#x000b1;&#x02009;0.03</td><td>0.70&#x02009;&#x000b1;&#x02009;0.04</td></tr></tbody></table><table-wrap-foot><p>Values were mean&#x02009;&#x000b1;&#x02009;SEM. HIT, high-intensity interval training group; MCT, moderate-intensity continuous training group; CTL, control group; Pre, pre-intervention; Post, post-intervention; R, resting; HE, hypoxic exercise test. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, R vs. HE.</p></table-wrap-foot></table-wrap>
<fig id="Fig1"><label>Figure 1</label><caption><p>Graph showing the effect of high-intensity interval training (<bold>HIT</bold>) on mitochondrial content, mitochondrial membrane potential, and matrix oxidant burden in platelets using a FACScan flow cytometer. <bold>Pre</bold>, before HIT; <bold>Post</bold>, after HIT; <bold>R</bold>, resting; <bold>HE</bold>, hypoxic (12%O<sub>2</sub>) exercise test. <bold>Blank (a&#x02013;d)</bold>, platelets without treating fluorescent dye; <bold>Mitochondrial content (e&#x02013;h)</bold>, platelets stained with MitoTracker Green FM; <bold>Mitochondrial membrane potential (i&#x02013;l)</bold>, platelet stained with tetramethylrhodamine ethyl ester; <bold>Matrix oxidant burden (m&#x02013;p)</bold>, platelet stained with MitoSOX Red; <bold>MFI</bold>, mean fluorescence intensity.</p></caption><graphic xlink:href="41598_2017_4035_Fig1_HTML" id="d29e1400"/></fig>
<fig id="Fig2"><label>Figure 2</label><caption><p>Effects of interval and continuous exercise regimens on <bold>(a&#x02013;c)</bold> mitochondrial content, <bold>(d&#x02013;f)</bold> mitochondrial membrane potential, and <bold>(g&#x02013;i</bold>) matrix oxidant burden in platelets. <bold>HIT</bold>, high-intensity interval training group <bold>(a</bold>,<bold>d</bold>,<bold>g)</bold>; <bold>MCT</bold>, moderate-intensity continuous training <bold>(b</bold>,<bold>e</bold>,<bold>h)</bold>; <bold>CTL</bold>, control group <bold>(c</bold>,<bold>f</bold>,<bold>i)</bold>; <bold>Pre</bold>, pre-intervention; <bold>Post</bold>, post-intervention; <bold>R</bold>, resting; <bold>HE</bold>, hypoxic (12%O<sub>2</sub>) exercise test; <bold>MFI</bold>, mean fluorescence intensity. <bold>*</bold>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <bold>R</bold> vs. <bold>HE</bold>; <sup>+</sup>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <bold>Pre</bold> vs. <bold>Post</bold>. Values were mean&#x02009;&#x000b1;&#x02009;SEM.</p></caption><graphic xlink:href="41598_2017_4035_Fig2_HTML" id="d29e1501"/></fig>
</p><p id="Par8">In mitochondrial biogenesis, acute HE did not change the levels of Complex IV and II, as well as, the ratio of Complex IV to II in platelets (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Furthermore, no significant changes in these mitochondrial biogenetic variables of platelets occurred after 6-week interventions with HIT, MCT, or CTL (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).</p></sec><sec id="Sec5"><title>Mitochondrial respiration of platelets</title><p id="Par9">Figures&#x000a0;<xref rid="Fig3" ref-type="fig">3a&#x02013;h</xref> show the analysis of O<sub>2</sub> consumption rate (OCR) in the intact (3a&#x02013;3d) and permeabilized (3e&#x02013;3h) platelets using high-resolution respirometry (Oroboros O2K). An acute bout of 12%O<sub>2</sub> exercise significantly decreased ATP-linked OCR (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a&#x02013;c</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and the reserve capacity of OCR (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4g&#x02013;i</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) in intact platelets. The HE also suppressed the fatty acid oxidation (FAO)- (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5d&#x02013;f</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), Complex I- (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5g&#x02013;i</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), and Complex II- (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5j&#x02013;l</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) mediated OCRs in permeabilized platelets. After 6 weeks, both HIT and MCT significantly elevated the reserve capacity of OCR in intact platelets at rest (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4g and h</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), whereas only HIT alleviated the suppression of the OCR reserve capacity caused by HE (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4g</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). Moreover, the two exercise regimens enhanced the Complex II-mediated OCR at rest (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5j and k</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), while only HIT diminished the depression of FAO- (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5d</xref>), Complex I- (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5g</xref>), and Complex II- (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5j</xref>) mediated OCRs and the capacity for electron transport system (ETS) (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5p</xref>) in platelets caused by HE. However, there were no significant changes in the HE-mediated mitochondrial respiration of platelets after 6 weeks of CTL (Figs&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig3"><label>Figure 3</label><caption><p>Graph showing measurement of mitochondrial O<sub>2</sub> consumption rate (OCR) in platelets using a high-resolution respirometry (Oroboros O2K). <bold>(a&#x02013;d)</bold>, the OCR protocol in intact platelets; <bold>(e&#x02013;h)</bold>, the OCR [substrate, uncoupler, inhibitor titration (SUIT)] protocol in permeabilized platelets. <bold>Omy</bold>, oligomycin; <bold>FCCP</bold>, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone; <bold>Rot</bold>, rotenone; <bold>AA</bold>, antimycin A; <bold>M</bold>, malate; <bold>C</bold>, palmitoyl-DL carnitine-HCl; <bold>Dig</bold>, digitonin; <bold>ADP</bold>, adenosine diphosphate; <bold>P</bold>, pyruvate; <bold>G</bold>, glutamate; <bold>S</bold>, succinate; <bold>Cyst C</bold>, cytochrome c; <bold>MA</bold>, malonic acid; <bold>Mt</bold>, myxothiazol. <bold>Pre</bold>, before high-intensity interval training (HIT); <bold>Post</bold>, after HIT; <bold>R</bold>, resting; <bold>HE</bold>, hypoxic (12%O<sub>2</sub>) exercise test.</p></caption><graphic xlink:href="41598_2017_4035_Fig3_HTML" id="d29e1672"/></fig>
<fig id="Fig4"><label>Figure 4</label><caption><p>Effects of interval and continuous exercise regimens on mitochondrial O<sub>2</sub> consumption rate (OCR) in the intact platelets. <bold>HIT (a</bold>,<bold>d</bold>,<bold>g</bold>,<bold>j</bold>,<bold>m)</bold>, high-intensity interval training group; <bold>MCT (b</bold>,<bold>e</bold>,<bold>h</bold>,<bold>k</bold>, <bold>n)</bold>, moderate-intensity continuous training; <bold>CTL (c</bold>,<bold>f</bold>,<bold>i</bold>,<bold>l</bold>,<bold>o)</bold>, control group; <bold>Pre</bold>, pre-intervention; <bold>Post</bold>, post-intervention; <bold>R</bold>, resting; <bold>HE</bold>, hypoxic (12%O<sub>2</sub>) exercise test; <bold>ATP</bold>, ATP-linked OCR; <bold>Uncouple</bold>, uncouple OCR; <bold>RESERVE</bold>, the reserve capacity of OCR; <bold>ROX</bold>, residual O<sub>2</sub> consumption. <bold>*</bold>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <bold>R</bold> vs. <bold>HE</bold>; <sup>+</sup>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <bold>Pre</bold> vs. <bold>Post</bold>. Values were mean&#x02009;&#x000b1;&#x02009;SEM.</p></caption><graphic xlink:href="41598_2017_4035_Fig4_HTML" id="d29e1789"/></fig>
<fig id="Fig5"><label>Figure 5</label><caption><p>Effects of interval and continuous exercise regimens on mitochondrial O<sub>2</sub> consumption rate (OCR) in the permeabilized platelets. <bold>HIT (a</bold>,<bold>d</bold>,<bold>g</bold>,<bold>j</bold>,<bold>m</bold>,<bold>p</bold>,<bold>s)</bold>, high-intensity interval training group; <bold>MCT (b</bold>,<bold>e</bold>,<bold>h</bold>,<bold>k</bold>,<bold>n</bold>,<bold>q</bold>,<bold>t)</bold>, moderate-intensity continuous training; <bold>CTL (c</bold>,<bold>f</bold>,<bold>i</bold>,<bold>l</bold>,<bold>o</bold>,<bold>r</bold>,<bold>u)</bold>, control group; <bold>Pre</bold>, pre-intervention; <bold>Post</bold>, post-intervention; <bold>R</bold>, resting; <bold>HE</bold>, hypoxic (12%O<sub>2</sub>) exercise test; <bold>ATP</bold>, ATP-linked OCR; <bold>FAO</bold>, fatty acid oxidation; <bold>ETS</bold>, electron transport system; <bold>CI</bold>, Complex I respiration; <bold>CII</bold>, Complex I respiration; <bold>ROX</bold>, Residual O<sub>2</sub> consumption. <bold>*</bold>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <bold>Rt</bold> vs. <bold>HE</bold>; <sup>+</sup>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <bold>Pre</bold> vs. <bold>Post</bold>. Values were mean&#x02009;&#x000b1;&#x02009;SEM.</p></caption><graphic xlink:href="41598_2017_4035_Fig5_HTML" id="d29e1932"/></fig>
</p><p id="Par10">Before various interventions, the HE test also suppressed the bioenergetics health index (BHI) value in platelets (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a&#x02013;c</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). After 6 weeks, both HIT (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and MCT (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6b</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) significantly elevated the BHI value in platelets at rest, whereas only HIT attenuated the suppression of BHI caused by HE (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). However, the activities of Complex IV in platelet mitochondria at rest or after HE remained unchanged following 6 weeks of HIT, MCT, or CTL (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6d&#x02013;f</xref>).<fig id="Fig6"><label>Figure 6</label><caption><p>Effects of interval and continuous exercise regimens on <bold>(a&#x02013;c</bold>) bioenergetics health index (BHI) and <bold>(d&#x02013;f)</bold> Complex IV activity in platelets. <bold>HIT</bold>, high-intensity interval training group <bold>(a</bold>,<bold>d)</bold>; <bold>MCT</bold>, moderate-intensity continuous training <bold>(b</bold>,<bold>e)</bold>; <bold>CTL</bold>, control group <bold>(c</bold>,<bold>f)</bold>; <bold>Pre</bold>, pre-intervention; <bold>Post</bold>, post-intervention; <bold>R</bold>, resting; <bold>HE</bold>, hypoxic (12%O<sub>2</sub>) exercise test. <bold>*</bold>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <bold>R</bold> vs. <bold>HE</bold>; <sup>+</sup>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <bold>Pre</bold> vs. <bold>Post</bold>. Values were mean&#x02009;&#x000b1;&#x02009;SEM.</p></caption><graphic xlink:href="41598_2017_4035_Fig6_HTML" id="d29e2048"/></fig>
</p></sec><sec id="Sec6"><title>Enzyme activities of glycolysis and the Krebs cycle in platelets</title><p id="Par11">Acute HE increased the activity of lactate dehydrogenase (LDH) and decreased the activities of citrate synthase (CS) and succinate dehydrogenase (SDH) in platelets (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). After 6 weeks of the intervention, HIT, but not MCT, attenuated the extents of the HE-enhanced LDH activity and the HE-depressed CS and SDH activities in platelets (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). However, the two exercise regimens did not influence the activities of hexokinase (HK) and pyruvate dehydrogenase (PDH) in platelets at rest and after HE (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Additionally, various enzyme activities of glycolysis and Krebs cycle in platelets at rest or after HE remained unchanged after 6 weeks of CTL (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>The effects of interval and continuous exercise regimens on enzyme activities of glycolysis and Krebs cycle in platelets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="2">HIT</th><th colspan="2">MCT</th><th colspan="2">CTL</th></tr><tr><th>Pre</th><th>Post</th><th>Pre</th><th>Post</th><th>Pre</th><th>Post</th></tr></thead><tbody><tr><td colspan="7">
<bold><italic>Glycolysis</italic></bold>
</td></tr><tr><td colspan="7">Hexokinase activity (nmol/min/10<sup>8</sup> cells)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>27.9&#x02009;&#x000b1;&#x02009;1.9</td><td>26.7&#x02009;&#x000b1;&#x02009;1.7</td><td>24.7&#x02009;&#x000b1;&#x02009;2.4</td><td>25.9&#x02009;&#x000b1;&#x02009;1.1</td><td>24.4&#x02009;&#x000b1;&#x02009;1.4</td><td>23.3&#x02009;&#x000b1;&#x02009;1.3</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>27.5&#x02009;&#x000b1;&#x02009;1.7</td><td>27.3&#x02009;&#x000b1;&#x02009;1.1</td><td>24.8&#x02009;&#x000b1;&#x02009;2.7</td><td>26.6&#x02009;&#x000b1;&#x02009;1.5</td><td>25.7&#x02009;&#x000b1;&#x02009;1.2</td><td>23.8&#x02009;&#x000b1;&#x02009;1.1</td></tr><tr><td colspan="7">Pyruvate dehydrogenase activity (nmol/min/10<sup>8</sup> cells)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>1.18&#x02009;&#x000b1;&#x02009;0.03</td><td>1.13&#x02009;&#x000b1;&#x02009;0.03</td><td>1.16&#x02009;&#x000b1;&#x02009;0.03</td><td>1.04&#x02009;&#x000b1;&#x02009;0.03</td><td>1.26&#x02009;&#x000b1;&#x02009;0.05</td><td>1.18&#x02009;&#x000b1;&#x02009;0.04</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>1.30&#x02009;&#x000b1;&#x02009;0.04</td><td>1.17&#x02009;&#x000b1;&#x02009;0.03</td><td>1.27&#x02009;&#x000b1;&#x02009;0.04</td><td>1.12&#x02009;&#x000b1;&#x02009;0.03</td><td>1.26&#x02009;&#x000b1;&#x02009;0.06</td><td>1.26&#x02009;&#x000b1;&#x02009;0.05</td></tr><tr><td colspan="7">Lactate dehydrogenase activity (nmol/min/10<sup>8</sup> cells)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>32.2&#x02009;&#x000b1;&#x02009;4.5</td><td>30.1&#x02009;&#x000b1;&#x02009;1.6</td><td>31.6&#x02009;&#x000b1;&#x02009;2.5</td><td>31.8&#x02009;&#x000b1;&#x02009;2.5</td><td>35.6&#x02009;&#x000b1;&#x02009;2.4</td><td>33.5&#x02009;&#x000b1;&#x02009;2.6</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>40.1&#x02009;&#x000b1;&#x02009;4.6*</td><td>33.6&#x02009;&#x000b1;&#x02009;1.5<sup>+</sup>
</td><td>41.2&#x02009;&#x000b1;&#x02009;2.4*</td><td>37.9&#x02009;&#x000b1;&#x02009;2.5*</td><td>42.5&#x02009;&#x000b1;&#x02009;2.2*</td><td>41.6&#x02009;&#x000b1;&#x02009;2.8*</td></tr><tr><td colspan="7">
<bold><italic>Krebs cycle</italic></bold>
</td></tr><tr><td colspan="7">Citrate synthase activity (nmol/min/10<sup>8</sup> cells)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>5.50&#x02009;&#x000b1;&#x02009;0.22</td><td>5.83&#x02009;&#x000b1;&#x02009;0.25</td><td>5.63&#x02009;&#x000b1;&#x02009;0.17</td><td>5.74&#x02009;&#x000b1;&#x02009;0.21</td><td>5.54&#x02009;&#x000b1;&#x02009;0.17</td><td>5.68&#x02009;&#x000b1;&#x02009;0.34</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>4.45&#x02009;&#x000b1;&#x02009;0.32*</td><td>5.88&#x02009;&#x000b1;&#x02009;0.43<sup>+</sup>
</td><td>4.61&#x02009;&#x000b1;&#x02009;0.24*</td><td>4.61&#x02009;&#x000b1;&#x02009;0.32*</td><td>4.52&#x02009;&#x000b1;&#x02009;0.24*</td><td>4.55&#x02009;&#x000b1;&#x02009;0.29*</td></tr><tr><td colspan="7">Succinate dehydrogenase activity (nmol/min/10<sup>8</sup> cells)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>9.46&#x02009;&#x000b1;&#x02009;0.82</td><td>9.59&#x02009;&#x000b1;&#x02009;1.32</td><td>9.37&#x02009;&#x000b1;&#x02009;0.91</td><td>9.62&#x02009;&#x000b1;&#x02009;0.83</td><td>9.12&#x02009;&#x000b1;&#x02009;0.42</td><td>9.41&#x02009;&#x000b1;&#x02009;0.45</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>6.77&#x02009;&#x000b1;&#x02009;0.91*</td><td>8.82&#x02009;&#x000b1;&#x02009;0.81<sup>+</sup>
</td><td>6.39&#x02009;&#x000b1;&#x02009;0.92*</td><td>6.83&#x02009;&#x000b1;&#x02009;0.72*</td><td>6.47&#x02009;&#x000b1;&#x02009;0.61*</td><td>6.57&#x02009;&#x000b1;&#x02009;0.60*</td></tr></tbody></table><table-wrap-foot><p>Values were mean&#x02009;&#x000b1;&#x02009;SEM. HIT, high-intensity interval training group; MCT, moderate-intensity continuous training group; CTL, control group; Pre, pre-intervention; Post, post-intervention; R, resting; HE, hypoxic exercise test. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, R vs. HE; <sup>+</sup>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <italic>P</italic>re vs. Post.</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec7"><title>Dynamic TG in platelet-rich plasma (PRP)</title><p id="Par12">Figure&#x000a0;<xref rid="Fig7" ref-type="fig">7a&#x02013;g</xref> show the samples of the HE-mediated dynamic TG in pretreating PRP with various mitochondrial modulators following 6 weeks of HIT. With respect to the analytic parameters of dynamic TG, acute HE increased the ETP (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), peak height (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), and rate (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8a&#x02013;c</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) of TG but not changed the lag time of TG (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>) in PRP before the intervention. Moreover, the changes of parameters of dynamic TG caused by HE were attenuated by pretreating PRP with oligomycin (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref> and Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8d&#x02013;f</xref>) or rotenone plus antimycin A (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref> and Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8j&#x02013;l</xref>). Six weeks of HIT (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7a&#x02013;d</xref>) and MCT (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7E&#x02013;H</xref>) significantly decreased the extents of HE-promoted ETP (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and peak height (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and rate (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8a</xref>, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) of TG in PRP. However, pretreating PRP with oligomycin (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>, Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8d&#x02013;f</xref>), rather than rotenone plus antimycin A (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref> and Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8j&#x02013;l</xref>), inhibited the training effects of HIT and MCT on the dynamic TG in PRP. Additionally, CLT did not significantly change the values of resting and HE-mediated dynamic TG parameters in untreated and oligomycin- or rotenone plus antimycin A-treated PRP (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref> and Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>).<fig id="Fig7"><label>Figure 7</label><caption><p>The calibrated, automatic thrombinographic analysis of high-intensity interval training (<bold>HIT</bold>) effect on dynamic thrombin generation in platelet-rich plasma (PRP). <bold>Pre-HIT</bold>, before HIT; <bold>Post-HIT</bold>, after HIT; <bold>R</bold>, resting; <bold>HE</bold>, hypoxic (12%O<sub>2</sub>) exercise test; <bold>Omy</bold>, oligomycin; <bold>FCCP</bold>, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone; <bold>Rot</bold>, rotenone; <bold>AA</bold>, antimycin A.</p></caption><graphic xlink:href="41598_2017_4035_Fig7_HTML" id="d29e2539"/></fig>
<table-wrap id="Tab4"><label>Table 4</label><caption><p>The effects of interval and continuous exercise regimens on dynamic thrombin generation in platelet-rich plasma.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="2">HIT</th><th colspan="2">MCT</th><th colspan="2">CTL</th></tr><tr><th>Pre</th><th>Post</th><th>Pre</th><th>Post</th><th>Pre</th><th>Post</th></tr></thead><tbody><tr><td colspan="7">
<bold><italic>Vehicle</italic></bold>
</td></tr><tr><td colspan="7">Lag time (min)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>9.1&#x02009;&#x000b1;&#x02009;0.1</td><td>9.0&#x02009;&#x000b1;&#x02009;0.1</td><td>9.1&#x02009;&#x000b1;&#x02009;0.2</td><td>8.9&#x02009;&#x000b1;&#x02009;0.1</td><td>9.1&#x02009;&#x000b1;&#x02009;0.2</td><td>9.1&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>9.1&#x02009;&#x000b1;&#x02009;0.1</td><td>9.0&#x02009;&#x000b1;&#x02009;0.1</td><td>9.2&#x02009;&#x000b1;&#x02009;0.1</td><td>8.9&#x02009;&#x000b1;&#x02009;0.1</td><td>9.2&#x02009;&#x000b1;&#x02009;0.2</td><td>9.3&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td colspan="7">ETP (mM&#x02009;&#x000d7;&#x02009;min)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>879&#x02009;&#x000b1;&#x02009;25</td><td>876&#x02009;&#x000b1;&#x02009;24</td><td>873&#x02009;&#x000b1;&#x02009;14</td><td>871&#x02009;&#x000b1;&#x02009;15</td><td>855&#x02009;&#x000b1;&#x02009;25</td><td>885&#x02009;&#x000b1;&#x02009;25</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>1105&#x02009;&#x000b1;&#x02009;34*</td><td>845&#x02009;&#x000b1;&#x02009;6<sup>+</sup>
</td><td>1101&#x02009;&#x000b1;&#x02009;35*</td><td>870&#x02009;&#x000b1;&#x02009;14<sup>+</sup>
</td><td>1103&#x02009;&#x000b1;&#x02009;42*</td><td>1139&#x02009;&#x000b1;&#x02009;48*</td></tr><tr><td colspan="7">Peak height (mM)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>50.7&#x02009;&#x000b1;&#x02009;1.7</td><td>45.5&#x02009;&#x000b1;&#x02009;1.2</td><td>52.2&#x02009;&#x000b1;&#x02009;1.3</td><td>49.6&#x02009;&#x000b1;&#x02009;1.4</td><td>50.3&#x02009;&#x000b1;&#x02009;3.7</td><td>51.0&#x02009;&#x000b1;&#x02009;1.2</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>70.1&#x02009;&#x000b1;&#x02009;3.2*</td><td>45.0&#x02009;&#x000b1;&#x02009;1.3<sup>+</sup>
</td><td>67.6&#x02009;&#x000b1;&#x02009;2.5*</td><td>49.1&#x02009;&#x000b1;&#x02009;1.7<sup>+</sup>
</td><td>71.6&#x02009;&#x000b1;&#x02009;5.1*</td><td>76.3&#x02009;&#x000b1;&#x02009;2.9*</td></tr><tr><td colspan="7">
<bold><italic>Oligomycin</italic></bold>
</td></tr><tr><td colspan="7">Lag time (min)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>8.9&#x02009;&#x000b1;&#x02009;0.1</td><td>9.0&#x02009;&#x000b1;&#x02009;0.1</td><td>8.9&#x02009;&#x000b1;&#x02009;0.1</td><td>8.8&#x02009;&#x000b1;&#x02009;0.1</td><td>8.8&#x02009;&#x000b1;&#x02009;0.2</td><td>8.7&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>8.8&#x02009;&#x000b1;&#x02009;0.1</td><td>8.9&#x02009;&#x000b1;&#x02009;0.1</td><td>8.8&#x02009;&#x000b1;&#x02009;0.1</td><td>8.7&#x02009;&#x000b1;&#x02009;0.1</td><td>8.8&#x02009;&#x000b1;&#x02009;0.2</td><td>8.9&#x02009;&#x000b1;&#x02009;02</td></tr><tr><td colspan="7">ETP (mM&#x02009;&#x000d7;&#x02009;min)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>779&#x02009;&#x000b1;&#x02009;31</td><td>795&#x02009;&#x000b1;&#x02009;17</td><td>791&#x02009;&#x000b1;&#x02009;17</td><td>791&#x02009;&#x000b1;&#x02009;14</td><td>795&#x02009;&#x000b1;&#x02009;25</td><td>782&#x02009;&#x000b1;&#x02009;20</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>825&#x02009;&#x000b1;&#x02009;32</td><td>788&#x02009;&#x000b1;&#x02009;29</td><td>845&#x02009;&#x000b1;&#x02009;18</td><td>803&#x02009;&#x000b1;&#x02009;17</td><td>846&#x02009;&#x000b1;&#x02009;25</td><td>834&#x02009;&#x000b1;&#x02009;41</td></tr><tr><td colspan="7">Peak height (mM)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>45.0&#x02009;&#x000b1;&#x02009;1.2</td><td>44.7&#x02009;&#x000b1;&#x02009;1.6</td><td>45.3&#x02009;&#x000b1;&#x02009;1.2</td><td>44.3&#x02009;&#x000b1;&#x02009;1.6</td><td>44.2&#x02009;&#x000b1;&#x02009;3.0</td><td>43.7&#x02009;&#x000b1;&#x02009;1.2</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>47.0&#x02009;&#x000b1;&#x02009;1.3</td><td>44.0&#x02009;&#x000b1;&#x02009;1.5</td><td>46.8&#x02009;&#x000b1;&#x02009;1.2</td><td>44.0&#x02009;&#x000b1;&#x02009;1.4</td><td>46.2&#x02009;&#x000b1;&#x02009;3.0</td><td>44.9&#x02009;&#x000b1;&#x02009;1.0</td></tr><tr><td colspan="7">
<bold><italic>Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone</italic></bold>
</td></tr><tr><td colspan="7">Lag time (min)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>6.9&#x02009;&#x000b1;&#x02009;0.2</td><td>7.0&#x02009;&#x000b1;&#x02009;0.1</td><td>6.9&#x02009;&#x000b1;&#x02009;0.2</td><td>7.0&#x02009;&#x000b1;&#x02009;0.1</td><td>7.0&#x02009;&#x000b1;&#x02009;0.3</td><td>6.9&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>6.7&#x02009;&#x000b1;&#x02009;0.2</td><td>7.0&#x02009;&#x000b1;&#x02009;0.1</td><td>6.9&#x02009;&#x000b1;&#x02009;0.2</td><td>6.9&#x02009;&#x000b1;&#x02009;0.1</td><td>6.9&#x02009;&#x000b1;&#x02009;0.2</td><td>7.1&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td colspan="7">ETP (mM&#x02009;&#x000d7;&#x02009;min)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>1005&#x02009;&#x000b1;&#x02009;23</td><td>955&#x02009;&#x000b1;&#x02009;22</td><td>1027&#x02009;&#x000b1;&#x02009;25</td><td>1032&#x02009;&#x000b1;&#x02009;21</td><td>1069&#x02009;&#x000b1;&#x02009;28</td><td>1040&#x02009;&#x000b1;&#x02009;26</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>1222&#x02009;&#x000b1;&#x02009;28*</td><td>951&#x02009;&#x000b1;&#x02009;20<sup>+</sup>
</td><td>1215&#x02009;&#x000b1;&#x02009;32*</td><td>1025&#x02009;&#x000b1;&#x02009;18<sup>+</sup>
</td><td>1252&#x02009;&#x000b1;&#x02009;30*</td><td>1243&#x02009;&#x000b1;&#x02009;33*</td></tr><tr><td colspan="7">Peak height (mM)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>78.1&#x02009;&#x000b1;&#x02009;3.4</td><td>79.2&#x02009;&#x000b1;&#x02009;2.9</td><td>82.6&#x02009;&#x000b1;&#x02009;2.8</td><td>76.8&#x02009;&#x000b1;&#x02009;2.9</td><td>83.6&#x02009;&#x000b1;&#x02009;6.1</td><td>87.3&#x02009;&#x000b1;&#x02009;2.1</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>108.1&#x02009;&#x000b1;&#x02009;3.4*</td><td>78.6&#x02009;&#x000b1;&#x02009;1.7<sup>+</sup>
</td><td>106.5&#x02009;&#x000b1;&#x02009;2.7*</td><td>79.4&#x02009;&#x000b1;&#x02009;2.62<sup>+</sup>
</td><td>111.7&#x02009;&#x000b1;&#x02009;7.2*</td><td>112.5&#x02009;&#x000b1;&#x02009;4.8*</td></tr><tr><td colspan="7">
<bold><italic>Rotenone plus Antimycin A</italic></bold>
</td></tr><tr><td colspan="7">Lag time (min)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>9.0&#x02009;&#x000b1;&#x02009;0.2</td><td>9.0&#x02009;&#x000b1;&#x02009;0.1</td><td>9.1&#x02009;&#x000b1;&#x02009;0.2</td><td>8.8&#x02009;&#x000b1;&#x02009;0.1</td><td>9.0&#x02009;&#x000b1;&#x02009;0.2</td><td>8.7&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>8.9&#x02009;&#x000b1;&#x02009;0.2</td><td>8.9&#x02009;&#x000b1;&#x02009;0.1</td><td>9.0&#x02009;&#x000b1;&#x02009;0.1</td><td>8.8&#x02009;&#x000b1;&#x02009;0.1</td><td>9.0&#x02009;&#x000b1;&#x02009;0.2</td><td>8.8&#x02009;&#x000b1;&#x02009;0.3</td></tr><tr><td colspan="7">ETP (mM&#x02009;&#x000d7;&#x02009;min)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;R</td><td>833&#x02009;&#x000b1;&#x02009;22</td><td>723&#x02009;&#x000b1;&#x02009;21<sup>+</sup>
</td><td>840&#x02009;&#x000b1;&#x02009;31</td><td>749&#x02009;&#x000b1;&#x02009;16<sup>+</sup>
</td><td>833&#x02009;&#x000b1;&#x02009;20</td><td>829&#x02009;&#x000b1;&#x02009;26</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>847&#x02009;&#x000b1;&#x02009;20</td><td>735&#x02009;&#x000b1;&#x02009;21<sup>+</sup>
</td><td>879&#x02009;&#x000b1;&#x02009;27</td><td>754&#x02009;&#x000b1;&#x02009;13<sup>+</sup>
</td><td>859&#x02009;&#x000b1;&#x02009;24</td><td>841&#x02009;&#x000b1;&#x02009;24</td></tr><tr><td colspan="7">Peak height (mM)</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;Rest</td><td>49.0&#x02009;&#x000b1;&#x02009;2.1</td><td>33.3&#x02009;&#x000b1;&#x02009;0.9<sup>+</sup>
</td><td>45.3&#x02009;&#x000b1;&#x02009;1.8</td><td>34.7&#x02009;&#x000b1;&#x02009;1.3<sup>+</sup>
</td><td>46.4&#x02009;&#x000b1;&#x02009;3.0</td><td>47.0&#x02009;&#x000b1;&#x02009;1.3</td></tr><tr><td>&#x000a0;&#x000a0;&#x000a0;HE</td><td>50.4&#x02009;&#x000b1;&#x02009;1.7</td><td>32.6&#x02009;&#x000b1;&#x02009;1.0<sup>+</sup>
</td><td>48.1&#x02009;&#x000b1;&#x02009;1.5</td><td>37.0&#x02009;&#x000b1;&#x02009;1.8<sup>+</sup>
</td><td>49.8&#x02009;&#x000b1;&#x02009;3.1</td><td>47.8&#x02009;&#x000b1;&#x02009;1.5</td></tr></tbody></table><table-wrap-foot><p>Values were mean&#x02009;&#x000b1;&#x02009;SEM. HIT, high-intensity interval training group; MCT, moderate-intensity continuous training group; CTL, control group; Pre, pre-intervention; Post, post-intervention; R, resting; HE, hypoxic exercise test; ETP, endogenous thrombin potential. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, R vs. HE; <sup>+</sup>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <italic>P</italic>re vs. Post.</p></table-wrap-foot></table-wrap>
<fig id="Fig8"><label>Figure 8</label><caption><p>Effects of interval and continuous exercise regimens on the rate of thrombin generation in platelet-rich plasma. <bold>HIT</bold> (<bold>a</bold>,<bold>d</bold>,<bold>g</bold>,<bold>j)</bold>, high-intensity interval training group; <bold>MCT (b</bold>,<bold>e</bold>,<bold>h</bold>,<bold>k</bold>), moderate-intensity continuous training; <bold>CTL</bold> (<bold>c</bold>,<bold>f</bold>,<bold>i</bold>,<bold>l)</bold>, control group; <bold>Pre</bold>, pre-intervention; <bold>Post</bold>, post-intervention; <bold>R</bold>, resting; <bold>HE</bold>, hypoxic (12%O<sub>2</sub>) exercise test; <bold>ETP</bold>, endogenous thrombin potential; <bold>Omy</bold>, oligomycin; <bold>FCCP</bold>, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone; <bold>Rot</bold>, rotenone; <bold>AA</bold>, antimycin A. <bold>*</bold>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <bold>R</bold> vs. <bold>HE</bold>; <sup>+</sup>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <bold>Pre</bold> vs. <bold>Post</bold>. Values were mean&#x02009;&#x000b1;&#x02009;SEM.</p></caption><graphic xlink:href="41598_2017_4035_Fig8_HTML" id="d29e3368"/></fig>
</p></sec></sec><sec id="Sec8" sec-type="discussion"><title>Discussion</title><p id="Par13">Mitochondrial dysfunction is associated with oxidative stress and thought to be a common underlying mechanism of metabolic and cardiovascular diseases<sup><xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref></sup>. This study is the first to demonstrate that acute bout of 12% O<sub>2</sub> exercise elevates mitochondrial oxidative stress and subsequently suppresses the CS and SDH activities and the ETS efficiency in platelets, which responses are accompanied by accelerating TG in PRP. Notably, the HIT regimen effectively ameliorates the HE-induced mitochondrial dysfunction of platelets by depressing the cellular oxidative stress, which may reduce the risk of platelet-mediated TG evoked by hypoxia.</p><sec id="Sec9"><title>Mitochondrial oxidative phosphorylation in platelets</title><p id="Par14">Mitochondria are highly sensitive to hypoxic stress and respond dynamically to changes in their cellular microenvironment<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. The present study showed that acute HE decreased mitochondrial MP and increased MOB in platelets, which may reflect mitochondrial oxidative damage of platelets caused by HE. Additionally, the HE-induced decrease in ATP-linked OCR and reserve capacity of OCR may be associated with modified activities of mitochondrial enzymes and/or an impeded the flow of electrons, thereby decreasing the ETS efficiency after HE. Acute HE also significantly decreased the CS and SDH activities and was accompanied by increased the LDH activity, suggesting that the HE shifts platelet metabolic pathways from mitochondrial respiration to glycolysis<sup><xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref></sup>. Furthermore, the HE substantially depressed the capacity of Complex I- and II-related respirations and the efficiency of ETS in platelets in a substrate-rich environment. Summarily, acute HE globally decreases mitochondrial substrate availability and impairs mitochondrial bioenergetics and/or integrity in platelets.</p><p id="Par15">In this investigation, the HIT regimen significantly enhanced platelet CS and SDH activities, as well as, Complex I- and II-related respirations following HE. The enhanced OCR of platelets by HIT may indicate a greater capacity of mitochondrial OXPHOS in platelets due to increased Complex protein activities of the ETS, elevated ATP production rate, or heightened levels of NADH and FADH<sub>2</sub>. Moreover, increased resistance to the HE-depressed platelet mitochondrial OCR after HIT may improve the flexibility of platelet activation caused by HE. A recent study has indicated that hypoxia or ischemia results in accumulation of intracellular succinate levels, thus leading to elevated mitochondrial ROS production<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. The elevation of oxidative stress may also induce succinate accumulation by decreasing SDH activity<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Therefore, the increased SDH activity and Complex II respiration of platelets in the HIT groups may quickly eliminate succinate, thereby further retarding the ROS production from platelet mitochondria following HE.</p></sec><sec id="Sec10"><title>Mitochondrial biogenesis in platelets</title><p id="Par16">Early studies on exercise intervention predominantly focused on mitochondrial functionality in skeletal muscles<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. An acute bout of exercise promotes transcriptional or post-translational regulation of peroxisome proliferator-activated receptor gamma coactivator-1&#x003b1;, whereas chronic exercise increases the rates of muscular mtDNA gene expression by upregulating Tfam in skeletal muscles<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. In the present study, no significant changes in resting and HE-related platelet biogenetic parameters, such as the Complex IV/II ratio, were observed after 6 weeks of HIT or MCT. Accordingly, we propose that platelet metabolic adaptation induced by HIT may be associated with improved ETS efficiency rather than modulated mitochondrial biogenesis in platelets.</p></sec><sec id="Sec11"><title>Dynamic TG in PRP</title><p id="Par17">Extremely hypoxic environments are associated with increased incidence of vascular thromboemoblic events<sup><xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref></sup>. Blood is subjected to oxidative stress during extremely hypoxic exposure<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>; elevated oxidative stress may contribute to coagulation system<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> and platelet activation<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. In the present study, acute HE facilitated TG in PRP and was accompanied by lost mitochondrial MP and increased MOB in platelets. Hence, increased ROS level by changed coupling of mitochondrial ETS may participate in platelet-mediated TG undergoing hypoxic stress. However, HIT for 6 week markedly depresses the HE-induced oxidative damage of platelet mitochondria and consequently attenuates the platelet-mediated TG caused by HE.</p></sec><sec id="Sec12"><title>Limitations of study</title><p id="Par18">Our small size in each group (n&#x02009;=&#x02009;15) is a major limitation of this study. However, the results of aerobic capacity and mitochondrial bioenergetics and dynamic TG in platelets obtained from this investigation have high values of statistical power from 0.853 to 1.000. Additionally, the subjects used tended to be young, males, and healthy, thus further clinical evidence was required to extrapolate the present results to the elderly, females or patients with platelet or thrombotic disorders.</p><p id="Par19">In this study, acute bout of HE promoted dynamic TG in PRP, whereas pretreating PRP with mitochondrial ETS inhibitors attenuated acute exercise effects. Moreover, 6 weeks of HIT also suppressed the extent of HE-promoted dynamic TG in PRP. Whether the suppression of HE-induced TG in PRP caused by HIT involves (i) change of plasma composition or/and (ii) down-regulation of procoagulant factors on platelets to diminish the enhancement of plasma TG by HE remains unresolved. Hence, the potential confounding effects of the different plasma compositions at various experimental conditions need further study.</p><p id="Par20">Aim of this study mainly focus on examining the effects of exercise on platelet-induced TG rather than platelet reactivity (adhesion and aggregation). Our previous studies have investigated the effect of exercise training on platelet adhesiveness and aggregability and their underling mechanisms<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. However, the role of platelet mitochondrial function on exercise-mediated platelet reactivity requires further explored.</p></sec><sec id="Sec13"><title>Conclusions</title><p id="Par21">Acute 12% O<sub>2</sub> exercise elevated oxidative stress and decreased the ETS efficiency in platelet mitochondria. Although no changes were found in mitochondrial biogenesis, 6 week of HIT enhanced mitochondrial OXPHOS capacity and attenuated the HE-depressed mitochondrial ETS efficiency in platelets. Therefore, the HIT regimen effectively improve platelet bioenergetics, possibly by enhancing mitochondrial quality rather than quantity in platelets. Moreover, HIT also markedly reduces the enhancement of platelet-mediated TG by HE, which response is associated with alleviating the HE-induced mitochondrial dysfunction of platelets. These experimental findings may facilitate the identification of effective exercise training regimens to increase aerobic capacity and minimize platelet mitochondrial dysfunction and subsequent thrombus formation evoked by hypoxic stress.</p></sec></sec><sec id="Sec14" sec-type="materials|methods"><title>Materials and Methods</title><sec id="Sec15"><title>Subjects</title><p id="Par22">The study was in accordance with the Declaration of Helsinki and approved by the Chang Gung Memorial Hospital Institutional Review Board, Taiwan. All experiments were performed in accordance with relevant guidelines and regulations. A total of 45 sedentary males who were non-smokers, did not use medications or vitamins, and were free of any cardiopulmonary/hematological risks were recruited from Chang Gung University, Taiwan. According to our previous studies, the menstrual phases of women influence activity of cardiac autonomic nervous system<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> and platelet reactivity<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Hence, this study excluded female subjects to avoid the effects of gender and the menstrual phase on cardiovascular<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> and hematological<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> functions. No subjects had engaged in any regular physical activity (exercise frequency&#x02009;&#x02264;&#x02009;once weekly, duration&#x02009;&#x0003c;&#x02009;20&#x02009;min) or had been exposed to high altitudes (&#x02265;altitude of 3000&#x02009;m) for at least 1 year before the experiment. All subjects provided informed consent after the experimental procedures were explained. These subjects were randomly divided into three groups: the HIT (n&#x02009;=&#x02009;15), MCT (n&#x02009;=&#x02009;15), and CTL (n&#x02009;=&#x02009;15) groups. Moreover, all subjects arrived at the testing center at 9:00 AM to eliminate any possible circadian effects. The experimental environment was maintained at a temperature of 22+/&#x02212; 0.5&#x02009;&#x000b0;C with a relative humidity of 60+/&#x02212; 5%. Participants were instructed to fast for at least 8&#x02009;hours and to refrain from strenuous physical exercise for at least 48&#x02009;hours before sampling.</p></sec><sec id="Sec16"><title>Training protocols</title><p id="Par23">Both the HIT and MCT groups performed exercise regimens on a stationary bicycle ergometer 5 times a week for 6 weeks. For comparison, CTL participants did not any undergo any exercise but were carefully monitored, and we recorded information on their physical activity and nutritional intake for 6 weeks. HIT subjects warmed up for 3&#x02009;min at 30% of VO<sub>2max</sub> before starting five exercise cycles, each lasting 3&#x02009;min at 80% of VO<sub>2max</sub> interspersed with a 3&#x02009;min active recovery period at 40% of VO<sub>2max</sub>. The exercise session was terminated with a 3&#x02009;min cool-down period at 30% of VO<sub>2max</sub>. The MCT group had the same warm-up and cool-down protocols as the HIT group, except that the training period was 30&#x02009;min at 60% of VO<sub>2max</sub>
<sup><xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR28">28</xref></sup>. The two exercise protocols were isovolumic with the same exercise duration [i.e., HIT exercise volume: 6&#x02009;min (40%VO<sub>2max</sub>&#x02009;+&#x02009;80%VO<sub>2max</sub>)&#x02009;&#x000d7;&#x02009;5 cycles&#x02009;=&#x02009;MCT exercise volume: 30&#x02009;min (60%VO<sub>2max</sub>)]. Each subject used a heart rate (HR) monitor (Tango, SunTech Medical) to obtain the assigned intensity of exercise. The work-rate of the bicycle ergometer was adjusted continuously to ensure that the intensity of exercise matched the target HR throughout the training period. The percentage of HR reserve (%HRR) is widely considered to be equivalent to the percentage of VO<sub>2</sub> reverse for exercise prescription purposes<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Accordingly, the target HRs of HIT and MCT were calculated using the following equations<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\rm{Peak}}\,{\rm{HR}}=220-{\rm{age}}$$\end{document}</tex-math><mml:math id="M20" display="block"><mml:mi mathvariant="normal">Peak</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">HR</mml:mi><mml:mo>=</mml:mo><mml:mn>220</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">age</mml:mi></mml:math><graphic xlink:href="41598_2017_4035_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{array}{c} \% {\rm{HHR}}= \% ({\rm{peak}}\,{\rm{HR}}-{\rm{resting}}\,{\rm{HR}})+{\rm{resting}}\,{\rm{HR}}\end{array}$$\end{document}</tex-math><mml:math id="M22" display="block"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mo>%</mml:mo><mml:mi mathvariant="normal">HHR</mml:mi><mml:mo>=</mml:mo><mml:mo>%</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi mathvariant="normal">peak</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">HR</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">resting</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">HR</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="normal">resting</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">HR</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="41598_2017_4035_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\rm{Target}}\,{\rm{HR}}\,{\rm{of}}\,{\rm{HIT}}=3-{\rm{minute}}\,{\rm{intervals}}\,{\rm{at}}\,40 \% \,{\rm{HHR}}\,{\rm{and}}\,80 \% \,{\rm{HRR}}$$\end{document}</tex-math><mml:math id="M24" display="block"><mml:mi mathvariant="normal">Target</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">HR</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">of</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">HIT</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">minute</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">intervals</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">at</mml:mi><mml:mspace width=".25em"/><mml:mn>40</mml:mn><mml:mo>%</mml:mo><mml:mspace width=".25em"/><mml:mi mathvariant="normal">HHR</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">and</mml:mi><mml:mspace width=".25em"/><mml:mn>80</mml:mn><mml:mo>%</mml:mo><mml:mspace width=".25em"/><mml:mi mathvariant="normal">HRR</mml:mi></mml:math><graphic xlink:href="41598_2017_4035_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\rm{Target}}\,{\rm{HR}}\,{\rm{of}}\,{\rm{MCT}}={\rm{sustained}}\,60 \% \,{\rm{HRR}}$$\end{document}</tex-math><mml:math id="M26" display="block"><mml:mi mathvariant="normal">Target</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">HR</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">of</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">MCT</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">sustained</mml:mi><mml:mspace width=".25em"/><mml:mn>60</mml:mn><mml:mo>%</mml:mo><mml:mspace width=".25em"/><mml:mi mathvariant="normal">HRR</mml:mi></mml:math><graphic xlink:href="41598_2017_4035_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula>
</p><p id="Par24">All subjects recorded their daily activities and nutritional intake throughout the experiment using the International Physical Activity Questionnaire Short Form<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> and the Written Diet Record<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, respectively. The participants were instructed to refrain from extra regular exercise until the end of the study. Moreover, the participant compliance rates for the three interventions were 100%. All subjects completed the exercise intervention and/or tests at the beginning of the present study and after 6 weeks in the three groups.</p></sec><sec id="Sec17"><title>GXT</title><p id="Par25">Subjects performed a GXT on a bicycle ergometer (Corival 400, Lode) to assess their aerobic capacity 4 days before and 4 days after the 6 week interventions<sup><xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR28">28</xref></sup>. The GXT was composed of 2&#x02009;min of unloaded pedaling followed by a continuous increase in work-rate of 30&#x02009;W per 3&#x02009;min until exhaustion (<italic>i</italic>.<italic>e</italic>., VO<sub>2max</sub>). The V<sub>E</sub>, VO<sub>2</sub>, and VCO<sub>2</sub> were measured breath by breath with a computer-based system (MasterScreen CPX, Cardinal-health Germany). The defined VO<sub>2max</sub> was required to achieve the following 3 of 4 criteria: (i) the level of VO<sub>2</sub> increased less than 2&#x02009;mL/kg/min over at least 2&#x02009;min; (ii) HR exceeded its predicted maximum; (iii) the respiratory exchange ratio exceeded 1.2, and (iv) the venous lactate concentration exceeded 8&#x02009;mM, consistently with the guidelines of the American College of Sports Medicine for exercise testing<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. The value of ventilatory threshold was determined by applying the following ventilatory criteria; (i) the V<sub>E</sub>/VO<sub>2</sub> ratio increased without a corresponding increase in the V<sub>E</sub>/VCO<sub>2</sub> ratio; (ii) PETO<sub>2</sub> increased without a decrease in the PETCO<sub>2</sub>, and (iii) a departure from linearity for V<sub>E</sub>
<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p></sec><sec id="Sec18"><title>The HE test and blood collection</title><p id="Par26">Each subject performed the HE test on the 2<sup>nd</sup> day before the intervention and on the 2<sup>nd</sup> day after the intervention in an air-conditioned normobaric hypoxia chamber (Colorado Mountain Room, Boulder, CO) as described in our previous studies<sup><xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR28">28</xref></sup>. The hypoxia chamber was maintained at a temperature of 22+/&#x02212; 0.5&#x02009;&#x000b0;C with a relative humidity of 60+/&#x02212; 5%; a CO<sub>2</sub> scrubber eliminated CO<sub>2</sub> in the air (&#x0003c;3,500&#x02009;ppm). The HE test on the bicycle ergometer required 50&#x02009;W of warm-up for 3&#x02009;min, an increase in the work-rate to 100&#x02009;W with continuous exercise for 30&#x02009;min, and then recovery to 50&#x02009;W of a cool-down period for 3&#x02009;min. During the test, the O<sub>2</sub> concentration was set to 12%, which corresponds to an altitude of 4,460&#x02009;m<sup><xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR29">29</xref></sup>. For safety reasons, the HE test was terminated immediately when the level of O<sub>2</sub> saturation dropped to &#x0003c;70% or the subject complained of discomfort. All subjects were free of acute mountain sickness symptoms during the experimental period.</p><p id="Par27">At rest and immediately after the HE test, 40&#x02009;ml blood samples were collected from an antecubital vein using a clean venipuncture (20 gauge needle). The first 2&#x02009;ml of blood was discarded, and the remaining blood was used to measure hematological parameters. Blood cells were counted using a Sysmax SF-3000 cell counter (GMI, Inc., Ramsey, MN).</p></sec><sec id="Sec19"><title>Platelet isolation</title><p id="Par28">Blood samples were collected in polypropylene tubes that contained sodium citrate (3.8&#x02009;g/dl, 1&#x02013;9 vol. blood). PRP was prepared by centrifugation at 300&#x02009;<italic>g</italic> for 10&#x02009;min at room temperature (20&#x02009;&#x000b0;C). Platelets were pelleted by centrifugation of the PRP at 1,500&#x02009;<italic>g</italic> for 10&#x02009;min and then washed once with phosphate buffered saline containing ethylenediaminetetraacetic acid (final concentration, 4&#x02009;mM) (Sigma) to prohibit platelet activation. The number of platelets was adjusted to 2&#x02009;&#x000d7;&#x02009;10<sup>8</sup> cells/ml with RPMI medium (Sigma). The tests of blood samples were repeated to ensure reproducibility. The analysis of platelet functions was completed within 2&#x02009;hours after cell purification.</p></sec><sec id="Sec20"><title>Mitochondrial content, MP, and MOB in platelets</title><p id="Par29">The relative quantification of platelet mitochondrial-localized dyes using the single-color flow cytometric analysis allows for the sensitive measurement of a variety of mitochondrial parameters, including mitochondrial content, MP, and MOB, as described in previous studies<sup><xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR33">33</xref></sup>. The platelet suspensions (2&#x02009;&#x000d7;&#x02009;10<sup>8</sup> cells/ml) were incubated with MitoTracker Green FM (a green-fluorescent mitochondrial stain, 200&#x02009;nM) (Invitrogen), tetramethylrhodamine ethyl ester (TMRE, a mitochondrial potential-sensitive probe, 20&#x02009;nM) (Invitrogen), or MitoSOX Red (a mitochondrial superoxide indicator, 6.6&#x02009;&#x003bc;M) (Invitrogen) in the dark for 30&#x02009;min at 4&#x02009;&#x000b0;C. Then, the platelets were gated separately from other particles on the basis of forward/sideways scatter, and the mean fluorescence intensity from 100,000 events representing the platelets was calculated using a FACScan flow cytometer (Becton Dickinson).</p></sec><sec id="Sec21"><title>Mitochondrial respiration and BHI in intact platelets</title><p id="Par30">The mitochondrial O<sub>2</sub> consumption of platelets (2&#x02009;&#x000d7;&#x02009;10<sup>8</sup> cells/ml) in RPMI 1460 medium was measured using high-resolution respirometry (Oroboros O2K). Mitochondrial respiration coupled towards ATP production (ATP-linked OCR) was measured by the fall in O<sub>2</sub> consumption following the addition of oligomycin (0.2&#x02009;&#x003bc;g/ml), an inhibitor of ATP synthase. The remaining rate of mitochondrial respiration represents a proton leak that uncouples OXPHOS from the ETS. The total O<sub>2</sub> consumption of platelets was measured at baseline and after the addition of the uncoupling agent carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP; 2&#x02009;&#x003bc;M) to induce maximal O<sub>2</sub> consumption. The difference between the basal and maximal respiration is called the reserve capacity of OCR. Non-mitochondrial respiration (non-mito OCR) was quantified by inhibiting mitochondrial respiration through the addition of rotenone (a mitochondrial Complex I inhibitor, 1&#x02009;&#x003bc;M) and antimycin A (a mitochondrial Complex III inhibitor, 1&#x02009;&#x003bc;M)<sup><xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR34">34</xref></sup>.</p><p id="Par31">The BHI was calculating from the result of coupling control protocol to quantify platelet mitochondrial function using the following equations<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>:<disp-formula id="Equ5"><label>1</label><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Log}[(\mathrm{ATP}-\mathrm{linked}\,{\rm{OCR}})\times ({\rm{Reserved}}\,{\rm{capacity}}\,{\rm{of}}\,{\rm{OCR}})/({\rm{Proton}}\,{\rm{leak}})\times (\mathrm{Non}-\mathrm{mito}\,{\rm{OCR}})]$$\end{document}</tex-math><mml:math id="M28" display="block"><mml:mi>Log</mml:mi><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi>ATP</mml:mi><mml:mo>-</mml:mo><mml:mi>linked</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">OCR</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>&#x000d7;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">Reserved</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">capacity</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">of</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">OCR</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>/</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi mathvariant="normal">Proton</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">leak</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>&#x000d7;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi>Non</mml:mi><mml:mo>-</mml:mo><mml:mi>mito</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">OCR</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:math><graphic xlink:href="41598_2017_4035_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ6"><label>2</label><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{ATP}-\mathrm{linked}\,{\rm{OCR}}={\rm{Routine}}\,{\rm{state}}-{\rm{Leak}}\,{\rm{state}}$$\end{document}</tex-math><mml:math id="M30" display="block"><mml:mi>ATP</mml:mi><mml:mo>-</mml:mo><mml:mi>linked</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">OCR</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">Routine</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">state</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">Leak</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">state</mml:mi></mml:math><graphic xlink:href="41598_2017_4035_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ7"><label>3</label><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\rm{Reserved}}\,{\rm{capacity}}={\rm{ETS}}\,{\rm{state}}-{\rm{Routine}}\,{\rm{state}}$$\end{document}</tex-math><mml:math id="M32" display="block"><mml:mi mathvariant="normal">Reserved</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">capacity</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">ETS</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">state</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">Routine</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">state</mml:mi></mml:math><graphic xlink:href="41598_2017_4035_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ8"><label>4</label><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Non}-\mathrm{mito}\,{\rm{OCR}}={\rm{Residual}}\,{{\rm{O}}}_{2}{\rm{consumption}}\,({\rm{ROX}}){\rm{state}}$$\end{document}</tex-math><mml:math id="M34" display="block"><mml:mi>Non</mml:mi><mml:mo>-</mml:mo><mml:mi>mito</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">OCR</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">Residual</mml:mi><mml:mspace width=".25em"/><mml:msub><mml:mrow><mml:mi mathvariant="normal">O</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mi mathvariant="normal">consumption</mml:mi><mml:mspace width=".25em"/><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi mathvariant="normal">ROX</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mi mathvariant="normal">state</mml:mi></mml:math><graphic xlink:href="41598_2017_4035_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ9"><label>5</label><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\rm{Proton}}\,{\rm{leak}}={\rm{Leak}}\,{\rm{state}}-{\rm{ROX}}\,{\rm{state}}$$\end{document}</tex-math><mml:math id="M36" display="block"><mml:mi mathvariant="normal">Proton</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">leak</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">Leak</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">state</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">ROX</mml:mi><mml:mspace width=".25em"/><mml:mi mathvariant="normal">state</mml:mi></mml:math><graphic xlink:href="41598_2017_4035_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula>
</p></sec><sec id="Sec22"><title>Mitochondrial respiration in permeablized platelets</title><p id="Par32">A substrate, uncoupler, inhibitor titration (SUIT) protocol was applied to permeablized platelets preparation and analyzed the respiration capacity of platelet mitochondria. By multiple substrate titration, electron flow from FAO and mitochondrial Complex I and II were well controlled, and the mitochondrial OCR of each state was measured by a high-resolution respirometry (Oroboros O2K)<sup><xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR34">34</xref></sup>.</p><p id="Par33">Intact platelets (2&#x02009;&#x000d7;&#x02009;10<sup>8</sup> cells/ml) were incubate at 37&#x02009;&#x000b0;C in the O2K chamber of mitochondria respiratory medium MiR05 (EGTA 0.5&#x02009;mM, MgCl<sub>2</sub>&#x02009;&#x000b7;&#x02009;6H<sub>2</sub>O 3&#x02009;mM, lactobionic acid 60&#x02009;mM, taurine 20&#x02009;mM, KH<sub>2</sub>PO<sub>4</sub> 10&#x02009;mM, HEPES 20&#x02009;mM, D-sucrose 110&#x02009;mM, and bovine serum albumin 1&#x02009;g/l, pH&#x02009;=&#x02009;7.1). Data acquisition was started after the oxygen flux stabilized. The O<sub>2</sub> consumption in this state was the routine respiration from endogenous substrates in cells. Then the plasma membrane was permeabilized by digitonin (0.1&#x02009;mg) titration after a concomitant addition of malate (2&#x02009;mM) and palmitoyl-DL-carnitine-HCl (20&#x02009;&#x003bc;M). Since the absence of adenylate in the chamber, the respiration in this state was caused by mitochondrial proton leakage (LEAK). The O<sub>2</sub> consumption by FAO was evaluated by addition of 1&#x02009;mM ADP (Calbiochem). Oxidative phosphorylation capacity of mitochondrial Complex I and II were acquired through the addition of NADH resources pyruvate (5&#x02009;mM) and glutamate (10&#x02009;mM) and SDH resource succinate (10&#x02009;mM). A cytochrome c (10&#x02009;&#x003bc;M) test was applied to evaluate whether the outer mitochondrial membrane was intact. The maximal convergent capacity of the ETS was subsequently obtained by FCCP titration (0.5&#x02009;&#x003bc;M/steps).</p><p id="Par34">Finally, the inhibitors for Complex I, II and III (0.1&#x02009;&#x003bc;M rotenone, 5&#x02009;mM malonic acid, and 0.5&#x02009;&#x003bc;M myxothiazol/2.5&#x02009;&#x003bc;M antimycin A) were progressively added to suppress the O<sub>2</sub> consumption of platelets mitochondria. At last, tetramethyl-p-phenylenediamine (TMPD, 0.5&#x02009;mM) applied as an artificial substrate for reducing cytochrome c, was added for cytochrome c oxidase activity measurement and then blocked by mitochondrial Complex IV inhibitor sodium azide (200&#x02009;mM). All chemicals were purchased from Sigma-Aldrich (St Louis, MO, USA) if not stated otherwise.</p></sec><sec id="Sec23"><title>Enzyme activities of glycolysis and the Krebs cycle in platelets</title><p id="Par35">The activities of HK (Sigma), PDH (BioVision), and LDH (Sigma) in glycolysis and the activities of CS (BioVision) and SDH (BioVision) in the Krebs cycle of platelets (1&#x02009;&#x000d7;&#x02009;10<sup>8</sup> cells/ml) were measured with commercially available colorimetric kits according to the manufacturer&#x02019;s instructions<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>.</p></sec><sec id="Sec24"><title>Dynamic TG assay</title><p id="Par36">The dynamic TG in PRP was measured by calibrated, automatic thrombinography (Synapse/Thrombinoscope BV, Maastricht, the Netherlands), as described in our earlier works<sup><xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR13">13</xref></sup>. Oligomycin (2&#x02009;&#x003bc;g/ml), FCCP (3.75&#x02009;&#x003bc;M), or rotenone (0.1 &#x003bc;M) plus antimycin A, (2.5 &#x003bc;M) were added to the PRP (2&#x02009;&#x000d7;&#x02009;10<sup>8</sup> cells/ml), which was then warmed to 37&#x02009;&#x000b0;C for 10&#x02009;min. Following incubation, eighty microliters of the PRP samples were allocated into the wells of round bottom 96-well microtiter plates (Nunc). Twenty microliters of reagent containing tissue factor (TF) was mixed with the plasma samples to obtain a final concentration of 0.5 pM TF. Coagulation was started by adding 0.1&#x02009;M CaCl<sub>2</sub> (20&#x02009;&#x003bc;L) in a fresh mixture of fluobuffer (containing 20&#x02009;mM HEPES and 60&#x02009;mg/mL bovine serum albumin in pH 7.35) containing 2.5&#x02009;mM Z-Gly-Gly-Arg-AMC (the fluorogenic substrate) (Synapse/Thrombinoscope BV, Maastricht, the Netherlands). Upon cleaving by thrombin, the fluorescent AMC (7-amino-4-methylcoumarin) is released and measured with a 390-nm-excitation and a 460-nm-emission filter set in an Ascent Fluoroskan (Thermo Fisher Scientific Inc., the Netherlands). All reagents were warmed to 37&#x02009;&#x000b0;C before the experiment began. Fluorescence was recorded for 60&#x02009;min. The fluorescence signal was corrected for substrate consumption, plasma colour variability and inner filter fluorescence effect by running in parallel calibrating wells where 80 microliters plasma samples were mixed with 20 microliters Thrombin Calibrator from Thrombinoscope BV.</p><p id="Par37">The calculated data using analytic software from Synapse/Thrombinoscope BV were plotted and expressed in terms of lag time (time until initial thrombin formation, min), endogenous thrombin potential (ETP, area under the thrombin curve, nM&#x02009;&#x000d7;&#x02009;min), the peak height of thrombin (nM), and the rate of TG (mean slope&#x02009;=&#x02009;peak height/[time to peak-lag time], nM/min)<sup><xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR13">13</xref></sup>.</p></sec><sec id="Sec25"><title>Statistical analysis</title><p id="Par38">The results are expressed as the mean&#x02009;&#x000b1;&#x02009;SEM. The statistical software package StatView was used for data analysis. Experimental results in each group were analyzed by the repeated measures ANOVA and Bonferroni&#x02019;s post-hoc test to compare the count, mitochondrial OXPHOS, oxidative stress and biogenesis of platelets, as well as, the dynamic TG in PRP before and immediately after HE at the beginning of the present study and after 6 weeks. In addition, the comparison of cardiopulmonary fitness during GXT at the beginning of the present study and 6 weeks later in various groups was analyzed by the repeated measures ANOVA and Bonferroni&#x02019;s post-hoc test. The criterion for statistical significance was <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></sec></sec></body><back><fn-group><fn><p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to thank the volunteers for their enthusiastic participation in the present study. This work was supported by the National Science Council of Taiwan (grant number NSC 105-2314-B-182-013-MY3, 103-2314-B-182-005-MY3), Chang Gung Medical Research Program (grant number CMRPD3D0133, CMRPD1E0262), and Healthy Aging Research Center, Chang Gung University (grant number EMRPD1A0841).</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>Jong-Shyan Wang was involved in conception and design of research; Li-Hua Wu and Shao-Chiang Chang performed experiments; Jong-Shyan Wang and Li-Hua Wu analyzed data, interpreted results of experiments, prepared the Figures, and drafted the paper; Jong-Shyan Wang, Tieh-Cheng Fu, and Ching-Hui Huang edited and revised the paper; Li-Hua Wu, Shao-Chiang Chang, Tieh-Cheng Fu, Ching-Hui Huang, and Jong-Shyan Wang approved the final version of paper.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing Interests</title><p id="Par39">The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KW</given-names></name><name><surname>Lip</surname><given-names>GY</given-names></name></person-group><article-title>Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review</article-title><source>Arch Intern Med</source><year>2003</year><volume>163</volume><fpage>2368</fpage><lpage>2392</lpage><pub-id pub-id-type="doi">10.1001/archinte.163.19.2368</pub-id><pub-id pub-id-type="pmid">14581258</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KW</given-names></name><name><surname>Lip</surname><given-names>GY</given-names></name></person-group><article-title>Acute versus habitual exercise, thrombogenesis and exercise intensity</article-title><source>Thromb Haemost</source><year>2004</year><volume>91</volume><fpage>416</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">15025076</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kesaniemi</surname><given-names>YK</given-names></name><etal/></person-group><article-title>Dose-response issues concerning physical activity and health: an evidence-based symposium</article-title><source>Med Sci Sports Exerc</source><year>2001</year><volume>33</volume><fpage>S351</fpage><lpage>S358</lpage><pub-id pub-id-type="doi">10.1097/00005768-200106001-00003</pub-id><pub-id pub-id-type="pmid">11427759</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JS</given-names></name><name><surname>Cheng</surname><given-names>ML</given-names></name><name><surname>Yen</surname><given-names>HC</given-names></name><name><surname>Lou</surname><given-names>BS</given-names></name><name><surname>Liu</surname><given-names>HC</given-names></name></person-group><article-title>Vitamin E suppresses the enhancement of factor VIII-dependent thrombin generation by systemic hypoxia</article-title><source>Stroke</source><year>2009</year><volume>40</volume><fpage>656</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.108.517995</pub-id><pub-id pub-id-type="pmid">18948612</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>RQ</given-names></name><etal/></person-group><article-title>Hypoxia regulates the expression of tissue factor pathway signaling elements in a rat glioma model</article-title><source>Oncol Lett</source><year>2016</year><volume>12</volume><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">27347144</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Kanel</surname><given-names>R</given-names></name><name><surname>Dimsdale</surname><given-names>JE</given-names></name></person-group><article-title>Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease</article-title><source>Chest</source><year>2003</year><volume>124</volume><fpage>1956</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1378/chest.124.5.1956</pub-id><pub-id pub-id-type="pmid">14605073</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashitani</surname><given-names>J</given-names></name><name><surname>Mukae</surname><given-names>H</given-names></name><name><surname>Arimura</surname><given-names>Y</given-names></name><name><surname>Matsukura</surname><given-names>S</given-names></name></person-group><article-title>Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease</article-title><source>Intern Med</source><year>2002</year><volume>41</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.41.181</pub-id><pub-id pub-id-type="pmid">11929177</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalz</surname><given-names>J</given-names></name><name><surname>ten Cate</surname><given-names>H</given-names></name><name><surname>Spronk</surname><given-names>HM</given-names></name></person-group><article-title>Thrombin generation and atherosclerosis</article-title><source>J Thromb Thrombolysis</source><year>2014</year><volume>37</volume><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1007/s11239-013-1026-5</pub-id><pub-id pub-id-type="pmid">24241912</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zharikov</surname><given-names>S</given-names></name><name><surname>Shiva</surname><given-names>S</given-names></name></person-group><article-title>Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease</article-title><source>Biochem Soc Trans</source><year>2013</year><volume>41</volume><fpage>118</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1042/BST20120327</pub-id><pub-id pub-id-type="pmid">23356269</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obydennyy</surname><given-names>SI</given-names></name><name><surname>Sveshnikova</surname><given-names>AN</given-names></name><name><surname>Ataullakhanov</surname><given-names>FI</given-names></name><name><surname>Panteleev</surname><given-names>MA</given-names></name></person-group><article-title>Dynamics of calcium spiking, mitochondrial collapse and phosphatidylserine exposure in platelet subpopulations during activation</article-title><source>J Thromb Haemost</source><year>2016</year><volume>14</volume><fpage>1867</fpage><lpage>1881</lpage><pub-id pub-id-type="doi">10.1111/jth.13395</pub-id><pub-id pub-id-type="pmid">27343487</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Wang</surname><given-names>JS</given-names></name></person-group><article-title>Absolute hypoxic exercise training enhances <italic>in vitro</italic> thrombin generation by increasing procoagulant platelet-derived microparticles under high shear stress in sedentary men</article-title><source>Clin Sci (Lond)</source><year>2013</year><volume>124</volume><fpage>639</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1042/CS20120540</pub-id><pub-id pub-id-type="pmid">23252666</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JS</given-names></name><name><surname>Yen</surname><given-names>HL</given-names></name><name><surname>Yang</surname><given-names>CM</given-names></name></person-group><article-title>Warm-up exercise suppresses platelet-eosinophil aggregation and platelet-promoted release of eosinophil oxidant products enhanced by severe exercise under shear flow and inflammation in men</article-title><source>Thromb Haemost</source><year>2006</year><volume>207</volume><fpage>174</fpage><lpage>186</lpage></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Ho</surname><given-names>CW</given-names></name><name><surname>Tsai</surname><given-names>HH</given-names></name><name><surname>Wang</surname><given-names>JS</given-names></name></person-group><article-title>Interval and continuous exercise regimens suppress neutrophil-derived microparticle formation and neutrophil-promoted thrombin generation under hypoxic stress</article-title><source>Clin Sci (Lond)</source><year>2015</year><volume>128</volume><fpage>425</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1042/CS20140498</pub-id><pub-id pub-id-type="pmid">25371035</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n-Fern&#x000e1;ndez</surname><given-names>B</given-names></name><name><surname>Gredilla</surname><given-names>R</given-names></name></person-group><article-title>Mitochondria and oxidative stress in heart aging</article-title><source>Age (Dordr)</source><year>2016</year><volume>38</volume><fpage>225</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1007/s11357-016-9933-y</pub-id><pub-id pub-id-type="pmid">27449187</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walters</surname><given-names>JW</given-names></name><name><surname>Amos</surname><given-names>D</given-names></name><name><surname>Ray</surname><given-names>K</given-names></name><name><surname>Santanam</surname><given-names>N</given-names></name></person-group><article-title>Mitochondrial redox status as a target for cardiovascular disease</article-title><source>Curr Opin Pharmacol</source><year>2016</year><volume>27</volume><fpage>50</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2016.01.006</pub-id><pub-id pub-id-type="pmid">26894468</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mitochondrial dysfunction and oxidative stress in insulin resistance</article-title><source>Curr Pharm Des</source><year>2013</year><volume>19</volume><fpage>5730</fpage><lpage>5741</lpage><pub-id pub-id-type="doi">10.2174/13816128113199990373</pub-id><pub-id pub-id-type="pmid">23448492</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazure</surname><given-names>NM</given-names></name><name><surname>Brahimi-Horn</surname><given-names>MC</given-names></name><name><surname>Pouyss&#x000e9;gur</surname><given-names>J</given-names></name></person-group><article-title>Hypoxic mitochondria: accomplices in resistance</article-title><source>Bull Cancer</source><year>2011</year><volume>98</volume><fpage>40</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">21609892</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>HH</given-names></name><etal/></person-group><article-title>Exercise training alleviates hypoxia-induced mitochondrial dysfunction in the lymphocytes of sedentary males</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>35170</fpage><pub-id pub-id-type="doi">10.1038/srep35170</pub-id><pub-id pub-id-type="pmid">27731374</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000f6;nenberger</surname><given-names>MJ</given-names></name><name><surname>Kovacs</surname><given-names>WJ</given-names></name></person-group><article-title>Hypoxia signaling pathways: modulators of oxygen-related organelles</article-title><source>Front Cell Dev Biol</source><year>2015</year><volume>3</volume><fpage>42</fpage><pub-id pub-id-type="doi">10.3389/fcell.2015.00042</pub-id><pub-id pub-id-type="pmid">26258123</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouchani</surname><given-names>ET</given-names></name><etal/></person-group><article-title>Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS</article-title><source>Nature</source><year>2014</year><volume>515</volume><fpage>431</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1038/nature13909</pub-id><pub-id pub-id-type="pmid">25383517</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>E</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>LA</given-names></name></person-group><article-title>Succinate: a metabolic signal in inflammation</article-title><source>Trends Cell Biol</source><year>2014</year><volume>24</volume><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2013.11.008</pub-id><pub-id pub-id-type="pmid">24361092</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>HN</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Hood</surname><given-names>DA</given-names></name></person-group><article-title>Mitochondria, muscle health, and exercise with advancing age</article-title><source>Physiology (Bethesda)</source><year>2015</year><volume>30</volume><fpage>208</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">25933821</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotwal</surname><given-names>J</given-names></name><name><surname>Apte</surname><given-names>CV</given-names></name><name><surname>Kotwal</surname><given-names>A</given-names></name><name><surname>Mukherjee</surname><given-names>B</given-names></name><name><surname>Jayaram</surname><given-names>J</given-names></name></person-group><article-title>High altitude: a hypercoagulable state: results of a prospective cohort study</article-title><source>Thromb Res</source><year>2007</year><volume>120</volume><fpage>391</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.thromres.2006.09.013</pub-id><pub-id pub-id-type="pmid">17084442</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Ashraf</surname><given-names>MZ</given-names></name></person-group><article-title>Exposure to high altitude: a risk factor for venous thromboembolism?</article-title><source>Semin Thromb Hemost</source><year>2012</year><volume>38</volume><fpage>156</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1055/s-0032-1301413</pub-id><pub-id pub-id-type="pmid">22422330</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JS</given-names></name></person-group><article-title>Exercise prescription and thrombogenesis</article-title><source>J Biomed Sci</source><year>2006</year><volume>13</volume><fpage>753</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1007/s11373-006-9105-7</pub-id><pub-id pub-id-type="pmid">16933027</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Comparison of cardiac autonomic nervous system disturbed by sleep deprivation in sex and menstrual phase</article-title><source>Chin J Physiol</source><year>2015</year><volume>58</volume><fpage>114</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.4077/CJP.2015.BAD287</pub-id><pub-id pub-id-type="pmid">25858472</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JS</given-names></name><name><surname>Jen</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>HI</given-names></name></person-group><article-title>Effects of short-term exercise on female platelet function during different phases of the menstrual cycle</article-title><source>Arteriosclero Thromb Vasc Biol</source><year>1997</year><volume>17</volume><fpage>1682</fpage><lpage>1686</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.17.9.1682</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>TP</given-names></name><name><surname>Huang</surname><given-names>SC</given-names></name><name><surname>Chuang</surname><given-names>YF</given-names></name><name><surname>Wang</surname><given-names>JS</given-names></name></person-group><article-title>Effects of interval and continuous exercise training on CD4 lymphocyte apoptotic and autophagic responses to hypoxic stress in sedentary men</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e80248</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0080248</pub-id><pub-id pub-id-type="pmid">24236174</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swain</surname><given-names>DP</given-names></name><name><surname>Leutholtz</surname><given-names>BC</given-names></name><name><surname>King</surname><given-names>ME</given-names></name><name><surname>Haas</surname><given-names>LA</given-names></name><name><surname>Branch</surname><given-names>JD</given-names></name></person-group><article-title>Relationship between % heart rate reserve and %VO<sub>2</sub> reserve in treadmill exercise</article-title><source>Med Sci Sports Exerc</source><year>1988</year><volume>30</volume><fpage>318</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1097/00005768-199802000-00022</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PH</given-names></name><name><surname>Macfarlane</surname><given-names>DJ</given-names></name><name><surname>Lam</surname><given-names>TH</given-names></name><name><surname>Stewart</surname><given-names>SM</given-names></name></person-group><article-title>Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review</article-title><source>Int J Behav Nutr Phys Act</source><year>2011</year><volume>8</volume><fpage>115</fpage><pub-id pub-id-type="doi">10.1186/1479-5868-8-115</pub-id><pub-id pub-id-type="pmid">22018588</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega</surname><given-names>RM</given-names></name><name><surname>P&#x000e9;rez-Rodrigo</surname><given-names>C</given-names></name><name><surname>L&#x000f3;pez-Sobaler</surname><given-names>AM</given-names></name></person-group><article-title>Dietary assessment methods: dietary records</article-title><source>Nutr Hosp</source><year>2015</year><volume>31</volume><fpage>S38</fpage><lpage>S45</lpage></element-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">American College of Sports Medicine, General principle of exercise prescription. In ACSM&#x02019;s Guidelines for Exercise Testing and Prescription (Thompson, W. R., Gordon, N. F. &#x00026; Pescatello, L. S., eds), Lippincott Williams &#x00026; Wilkins, Philadelphia. pp. 152&#x02013;182, (2010).</mixed-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pendergrass</surname><given-names>W</given-names></name><name><surname>Wolf</surname><given-names>N</given-names></name><name><surname>Poot</surname><given-names>M</given-names></name></person-group><article-title>Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues</article-title><source>Cytometry A</source><year>2004</year><volume>61</volume><fpage>162</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1002/cyto.a.20033</pub-id><pub-id pub-id-type="pmid">15382028</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sj&#x000f6;vall</surname><given-names>F</given-names></name><etal/></person-group><article-title>Mitochondrial respiration in human viable platelets&#x02013;methodology and influence of gender, age and storage</article-title><source>Mitochondrion</source><year>2013</year><volume>13</volume><fpage>7</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.mito.2012.11.001</pub-id><pub-id pub-id-type="pmid">23164798</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chacko</surname><given-names>BK</given-names></name><etal/></person-group><article-title>The Bioenergetic Health Index: a new concept in mitochondrial translational research</article-title><source>Clin Sci (Lond)</source><year>2014</year><volume>127</volume><fpage>367</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1042/CS20140101</pub-id><pub-id pub-id-type="pmid">24895057</pub-id></element-citation></ref></ref-list></back></article>